Joshua Lee

Program Director, Fellowship in Addiction Medicine · NYU Grossman School of Medicine

Credentials: · · ·

History

“GLP-1 Outcomes with People Using Psychoactive Substances (GLOW-UPS): A Multi-Stage, Multi-Site Trial Among Persons Involved in the Criminal-Legal System
National Institute on Drug Abuse · UM1
Contact PI · $2.8M · New York University School of Medicine
2025–2030
Substance Abuse Research Education and Training (SARET)
National Institute on Drug Abuse · R25
Contact PI · $698.7K · New York University School of Medicine
2007–2027
Long-Acting Buprenorphine vs. Naltrexone Opioid Treatments in CJS-Involved Adults
National Institute on Drug Abuse · U01
Contact PI · $20.3M · New York University School of Medicine
2019–2026
Impact of Jail-Based Methadone on Overdose, Recidivism, HIV and Health Outcomes, and Costs in New York City, 2011-2017
National Institute on Drug Abuse · R01
Contact PI · $3.1M · New York University School of Medicine
2018–2025

Long-acting Buprenorphine vs. Naltrexone Opioid Treatments in CJS-involved Adults
Principal investigator · Completed · Phase 4
NYU Langone Health
2021–2025
XRB vs. SLB in Jail and at Re-entry: Pilot, Proof of Concept
Principal investigator · Completed · Phase 4
NYU Langone Health
2019–2020
Extended-Release Naltrexone Opioid Treatment at Jail Re-Entry
Principal investigator · Completed · Phase 4
NYU Langone Health
2014–2020
Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From Jail
Principal investigator · Completed · Phase 3
NYU Langone Health
2010–2013